Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Altria Group Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Altria Group Inc trades at $74.22 (market cap $119.49B). The key difference: Altria Group Inc is far larger — about 3.8× GE HealthCare Technologies Inc. Common Stock's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals.
| GEHC | MO | |
|---|---|---|
Market Cap | $31.07B | $119.49B |
Volume | 3,443,020 | 6,945,035 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $74.92 |
52-Week Low | $59.48 | $54.72 |
Enterprise Value | $39.53B | $141.70B |
Dividend Yield | 0.23% | 6.2% |
Typical Hold Time | — | 155 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Altria Group (MO) trades at $71.56, down 0.15% on the day, with a P/E of 15.07 and a net income margin of 39%. Recent earnings show mixed results, with a beat in Q1 2026 but a miss in Q4 2025 and Q2 2026. The technical outlook is bullish based on moving averages, but oscillators suggest caution. Strong cash flow supports a high dividend yield, though negative equity and regulatory risks persist.
The stock presents a high-yield opportunity with a solid dividend history, but faces headwinds from declining margins and a challenging regulatory environment. Analyst consensus is bullish with a $69.71 price target, yet investors must weigh the sustainability of dividends against underlying financial pressures and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
